Research Progress on Health Benefits and Implementation Strategies of Dietary Methionine Restriction

被引:0
|
作者
Lu M. [1 ]
Qian J. [1 ]
Yang Y. [1 ]
Xie Y. [1 ]
Le G. [2 ]
机构
[1] National Engineering Research Center of Wheat and Corn Further Processing, Henan University of Technology, Zhengzhou
[2] State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi
来源
Shipin Kexue/Food Science | 2023年 / 44卷 / 11期
关键词
health benefits; implementation strategies; metabolic syndrome; methionine restriction; prolonging lifespan; tumor;
D O I
10.7506/spkx1002-6630-20220408-088
中图分类号
学科分类号
摘要
Methionine is the only essential sulfur-containing amino acid required for the human body and is involved in important metabolic pathways including protein synthesis, transsulfuration, and one-carbon metabolism. However, in recent years, a large number of studies have shown that restricting dietary methionine intake exerts many physiological functions beneficial to body health. This article comprehensively summarizes the benefits of methionine restriction (MR) including promoting gut health, prolonging lifespan, reducing lipid accumulation and body mass, increasing insulin sensitivity, ameliorating diabetes, atherosclerosis and other cardiovascular diseases, improving learning and memory function, and anti-tumor and anti-cancer effects, as well as the effects of MR on bone and skeletal muscle function and protein synthesis. In addition, the strengths and weaknesses of five MR strategies including protein-restriction diet, vegan diet, diet formulation based on monomeric amino acid, oral methioninase, and injection of recombinant methioninase are reviewed in this article. It also discusses future major research directions, which may provide a theoretical reference for the development and application of new foods containing low levels of methionine and the realization of the health functions of MR. © 2023 Chinese Chamber of Commerce. All rights reserved.
引用
收藏
页码:367 / 378
页数:11
相关论文
共 116 条
  • [81] COALSON D, MECHAM J, STERN P, Et al., Reduced availability of endogenously synthesized methionine for S-adenosylmethionine formation in methionine-dependent cancer cells, Proceedings of the National Academy of Sciences, 79, 14, pp. 4248-4251, (1982)
  • [82] HOFFMAN R., Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey, Expert Opinion on Biological Therapy, 15, 1, pp. 21-31, (2015)
  • [83] HOFFMAN R M., Is the hoffman effect for methionine overuse analogous to the warburg effect for glucose overuse in cancer?, Methods in Molecular Biology, 1866, pp. 273-278, (2019)
  • [84] STERN P, HOFFMAN R., Elevated overall rates of transmethylation in cell lines from diverse human tumors, In Vitro, 20, 8, pp. 663-670, (1984)
  • [85] JUDDE J, ELLIS M, FROST P., Biochemical analysis of the role of transmethylation in the methionine dependence of tumor cells, Cancer Research, 49, 17, pp. 4859-4865, (1989)
  • [86] EPNER D, MORROW S, WILCOX M, Et al., Nutrient intake and nutritional indexes in adults with metastatic cancer on a phase I clinical trial of dietary methionine restriction, Nutrition and Cancer, 42, 2, pp. 158-166, (2002)
  • [87] HOFFMAN R., Clinical studies of methionine-restricted diets for cancer patients, Methods in Molecular Biology, 1866, pp. 95-105, (2019)
  • [88] KOZIOROWSKA J, MAZUROWA N, TAUTT J., Methionine dependence of virus-infected cells, Experimental Cell Research, 190, 2, pp. 290-293, (1990)
  • [89] LIAO M, LIU Y, YUAN J, Et al., Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19, Nature Medicine, 26, 6, pp. 842-844, (2020)
  • [90] CAO X., COVID-19: immunopathology and its implications for therapy, Nature Reviews Immunology, 20, 5, pp. 269-270, (2020)